default author photo

Loredana Sarmati

University of Rome Tor Vergata - Department of Systems Medicine

Via di Tor Vergata

Rome, Lazio 00133

Italy

  • University of Rome Tor Vergata - Department of Systems Medicine

SCHOLARLY PAPERS

3

DOWNLOADS

273

TOTAL CITATIONS

1

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

First Evidence of Pathogenic HERV-W Envelope Expression in T Lymphocytes in Association with the Respiratory Outcome of COVID-19 Patients

Number of pages: 23 Posted: 11 Jan 2021
Emanuela Balestrieri, Antonella Minutolo, Vita Petrone, Marialaura Fanelli, Marco Iannetta, Vincenzo Malagnino, Marta Zordan, Pietro Vitale, Benjamin Charvet, Branka Horvat, Sergio Bernardini, Enrico Garaci, Paolo Di Francesco, Paola Sinibaldi Vallebona, Loredana Sarmati, Sandro Grelli, Massimo Andreoni, Hervé Perron and Claudia Matteucci
University of Rome Tor Vergata - Department of Experimental Medicine, University of Rome Tor Vergata - Department of Experimental Medicine, University of Rome Tor Vergata - Department of Experimental Medicine, University of Rome Tor Vergata - Department of Experimental Medicine, University of Rome Tor Vergata - Department of Systems Medicine, University of Rome Tor Vergata - Department of Systems Medicine, University of Rome Tor Vergata - Department of Systems Medicine, University of Rome Tor Vergata - Infectious Diseases Clinic, ENS Lyon - International Center for Infectiology Research (CIRI), ENS Lyon - International Center for Infectiology Research (CIRI), University of Rome Tor Vergata - Department of Experimental Medicine, IRCCS San Raffaele Pisana, University of Rome Tor Vergata - Department of Experimental Medicine, University of Rome Tor Vergata - Department of Experimental Medicine, University of Rome Tor Vergata - Department of Systems Medicine, University of Rome Tor Vergata - Department of Experimental Medicine, University of Rome Tor Vergata - Faculty of Medicine and Surgery, Geneuro – Innovation and University of Rome Tor Vergata - Department of Experimental Medicine
Downloads 152 (488,442)
Citation 1

Abstract:

Loading...

cytokine storm, COVID-19, HERV-W. human endogenous retroviruses, inflammation, respiratory outcome, T-cell exhaustion

2.

Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)

Number of pages: 38 Posted: 05 Dec 2022
Ilaria Mastrorosa, Roberta Gagliardini, Francesco Segala, Annalisa Mondi, Patrizia Lorenzini, Carlotta Cerva, Eleonora Taddei, Francesca Bai, Alessandra Vergori, Marcantonio Negri, Carmela Pinnetti, Stefania Cicalini, Rita Murri, Valentina Mazzotta, Marta Camici, Silvia Mosti, Teresa Bini, Gaetano Maffongelli, Alessia Beccacece, Eugenia Milozzi, Marco Iannetta, Silvia Lamonica, Marisa Fusto, Maria Maddalena Plazzi, Sandrine Ottou, Miriam Lichtner, Massimo Fantoni, Massimo Andreoni, Loredana Sarmati, Roberto Cauda, Enrico Girardi, Emanuele Nicastri, Antonella D'Arminio Monforte, Fabrizio Palmieri, Antonella Cingolani, Francesco Vaia, Andrea Antinori and ESCAPE Study Group
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS - Section of Infectious Diseases, ASST Santi Paolo e Carlo, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS - Section of Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, ASST Santi Paolo e Carlo, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Rome Tor Vergata - Department of Systems Medicine, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Rome Tor Vergata - Faculty of Medicine and Surgery, University of Rome Tor Vergata - Department of Systems Medicine, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Milan - Clinic of Infectious Diseases and Tropical Medicine, Lazzaro Spallanzani National Institute for Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department and Independent
Downloads 64 (924,743)

Abstract:

Loading...

Interleukin-6 receptor inhibitors, Sarilumab, SARS-CoV-2 infection, Severe COVID-19 pneumonia, randomized clinical trial

3.

Covid-19 and Influenza Vaccination Among Adults Stably Engaged in HIV Care

Number of pages: 19 Posted: 27 Apr 2025
Grazia Alessio, Drieda Zace, Chrisopher Iain Jones, Andrea Di Lorenzo, Alessandra Imeneo, Vincenzo Malagnino, Elisabetta Teti, Loredana Sarmati, Marco Iannetta and Anna Maria Geretti
affiliation not provided to SSRN, University of Rome Tor Vergata, University of Sussex, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Rome Tor Vergata - Department of Systems Medicine, affiliation not provided to SSRN, University of Rome Tor Vergata - Department of Systems Medicine, University of Rome Tor Vergata - Department of Systems Medicine and University of Liverpool - National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in 31 Emerging and Zoonotic Infections
Downloads 57 (989,921)

Abstract:

Loading...

COVID-19, Influenza, mRNA vaccine, HIV, Uptake, CD4 count